Advances in statistical methods for cancer surveillance research: an age-period-cohort perspective.

Authors:
Rosenberg PS; Miranda-Filho A.

Journal:
Front Oncol

Publication Year: 2024

DOI:
10.3389/fonc.2023.1332429

PMCID:
PMC10889111

PMID:
38406174

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Front Oncol

Abbreviation: Front Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years.
Huang J; Chen Y; Li Z and 7 more (2024) - Transparency Score: 3/6
Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma.
Wang Y; Wang Y; He H and 1 more (2024) - Transparency Score: 3/6
Access to advanced healthcare services and its associated factors among patients with cervical canc…
Shimels T; Gashawbeza B; Gedif Fenta T. (2024) - Transparency Score: 3/6
A cohort profile of the Graham Roberts study cohort.
Russell B; Leech P; Wylie H and 17 more (2024) - Transparency Score: 3/6
A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therap…
Garg H; Bhandari M; Dursun F and 4 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. PR and AM-F are supported by the Intramural Research Program of the National Cancer Institute, Division of Cancer Epidemiology and Genetics. AM-F is also supported through an appointment to the National Cancer Institute (NCI) ORISE Research Participation Program under DOE contract number DE-SC0014664."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025